The androgenicity of progestins
- 16 January 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 98 (1) , S104-S110
- https://doi.org/10.1016/s0002-9343(99)80067-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterolContraception, 1993
- A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrelActa Obstetricia et Gynecologica Scandinavica, 1992
- Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptivesActa Obstetricia et Gynecologica Scandinavica, 1992
- Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical TrialsActa Obstetricia et Gynecologica Scandinavica, 1990
- A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular DiseasesNew England Journal of Medicine, 1988
- Gestoden, an innovative progestogenContraception, 1988
- Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and DesogestrelActa Obstetricia et Gynecologica Scandinavica, 1988
- Effects of three Low-Dose Oral Contraceptive Combinations on Sex Hormone Binding Globulin, Corticosteroid Binding Globulin and Antithrombin III Activity in Healthy Women: Two Monophasic Desogestrel Combinations (Containing 0.020 or 0.030 mg Ethinylestradiol) and One Triphasic Levonorgestrel CombinationActa Obstetricia et Gynecologica Scandinavica, 1987
- Binding of progestagens to receptor proteins in MCF-7 cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980